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Dichlorooxovanadium(IV) complexes of polypyridyl bases (B), viz., [VO(B)Cl2] (1 and 2) of N,N,N-donor ligands  
2-(2-pyridyl)-1,10-phenanthroline (pyphen in 1) and 3-(pyridin-2-yl)dipyrido[3,2-a:2',3'-c]phenazine (pydppz in 2) have 
been prepared, and their anticancer activity studied. The complexes show good solubility in most polar solvent and are  
non-electrolytes. They show 1:1 electrolytic property in 20% aqueous DMF, and 1:2 electrolytic character in 20% aqueous 
DMF upon photo-irradiation with visible light (400–700 nm). Complex 1 shows DNA crosslinking property on dissociation 
of the V-Cl bond(s) as ascertained from its DNA melting profile and ethidium bromide displacement assay. The complexes 
1 and 2 are photocytotoxic towards HeLa (IC50: 16.9 µM and 0.87 µM  respectively) and MCF-7 (IC50: 19.5 µM and 1.4 µM 
respectively) cancer cells, but exhibit less toxicity in normal embryonic fibroblast 3T3 cells with IC50 values of ~40 and  
~25 µM in visible light (400-700 nm) for complexes 1 and 2 respectively. Complex 2 also displays light induced plasmid  
DNA cleavage activity. The light-induced cellular damage leads to generation of reactive oxygen species followed by 
apoptotic cell death. 
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Polypyridyl bases 
Cisplatin and its analogues are well known 
chemotherapeutic agents.
1-4
 Cisplatin binds to the N
7
 
atoms of the guanine bases of nuclear DNA forming 
DNA crosslinks. These complexes behave as 
transcription inhibitors resulting in cell death.
5
 The 
rate of dissociation of the Pt-Cl bonds in the 
intracellular medium is a key factor for the overall 
efficacy of these drugs. The rapid dissociation of the 
chlorides of cisplatin in the cellular medium 
necessitated the development of carboplatin and 
oxaliplatin as two alternate platinum-based 
chemotherapeutic drugs with reduced Pt-O bond 
dissociation rates.
6
 The successful use of platinum-
based chemotherapeutic drugs has generated interest 
for other DNA crosslinkers in cancer chemotherapy.
7-9
 
Although DNA inter- and intra-strand crosslinking 
(ICL) agents such as mitomycin C, cisplatin and 
psoralen are found to be potent anticancer drugs, these 
agents suffer from dose-limiting toxic effects on 
normal cells and reduced efficacy due to nuclear 






complexes are reported to be less active than 
cisplatin
13,14 
and better activity is reported when used 
in combination with other drugs.
 
While the cytotoxic 
effects of titanocene dihalides are comparable to that 
of cisplatin, they are not preferred for cellular 
application due to their toxic side effects.
15,16 
Copper(II) complexes showing cytotoxic properties 
are also reported in the literature, but the mechanistic 
pathways for such redox active complexes are 
different from that of cisplatin and do not involve 
formation of any ICLs.
17-19 
The present work stems from our continued interest 
to design and develop the chemistry of new 
photoactive six coordinate oxovanadium(IV) 
complexes as novel DNA crosslinkers having two 
chloride ligands in cis or trans disposition to each 
other mimicking the four coordinate core of cis- or 
trans-platin. With this initiative, we have previously 
reported oxovanadium(IV) complexes showing  
DNA covalent binding and DNA crosslinking 
properties.
20-23
 Trans-dichlorooxovanadium(IV) complex 
of pyrenylterpyridine (VDC) was earlier developed as 




a photo-inducible DNA crosslinking agent.
20
 This 
VDC complex initially forms a mono-adduct with the 
DNA. It can be photo-activated to generate DNA 
interstrand crosslinks, eventually leading to cell death. 
Besides, the dichlorooxovanadium(IV) complexes 
having pendant photoactive borondipyrromethene 
(BODIPY) moieties are shown to be highly 
photocytotoxic due to their mitochondrial localization 
and mitochondrial DNA crosslinking properties.
21
 
Oxovanadium(IV) complexes of (anthracenyl)- 
terpyridine and triphenylphosphonium-appended 
(anthracenyl)terpyridine ligands are also reported  
to show DNA crosslinking ability, photocytotoxicity 





 complexes showed rapid 
dissociation of one chloride ligand, while the  
second chloride ligand becomes labile only on photo-
activation. Unlike the cisplatin mechanistic pathway 
involving rapid hydrolysis of both the Pt-Cl bonds, in 
these complexes the sequential dissociation of two 
chloride ligands by light activation makes such 
complexes unique wherein their activity can be 
controlled by light. The appendage of a photoactive 
moiety allows the complexes to show photo-induced 
cytotoxicity akin to photodynamic therapy (PDT) in 
which the drug on light-activation generates reactive 
oxygen species to damage the light exposed cells, 
while the non-exposed healthy cells remain 
unaffected.
24-26
 We have shown in a recent 
communication that the ancillary ligand plays an 
important role in ICL formation and in the cellular 
organelle localization.
23
 While the BODIPY 
complexes primarily localize in the mitochondria of 
the cells, appendage of the anthracenyl moiety leads 
to nuclear localization.
22
 Use of polypyridyl bases, 
viz. pyphen (pyridyl-1,10-phenanthroline) and pydppz 
(3-(pyridine-2-yl)dipyrido[3,2-a:2’,3’-c]phenazine) in 
the dichlorooxovanadium(IV) complexes leads to 
remarkable photo-induced DNA crosslinking and 
cytotoxicity giving low IC50 values in HeLa and 
MCF-7 cancer cells. 
Herein, we present the calf thymus (ct) DNA 
binding, plasmid pUC19 DNA cleavage activity of 
the complexes [VO(pyphen)Cl2] (1) and 
[VO(pydppz)Cl2] (2) to understand the nature of ROS 
generation. We have also carried out photocytotoxicity 
studies using 3T3 embryonic fibroblast normal cells, 
detection of reactive oxygen species (ROS) via 
dichlorofluorescein diacetate (DCFDA) assay and cell 
cycle analysis. This study also includes the evidence 
for DNA covalent crosslink formation with the 
dissociation of the chloride ligands from the DNA 
binding and cleavage studies. In this work DNA 
crosslink formation in visible light could be directly 
observed from DNA melting and comet assay data. 
Further, the photo-cytotoxicity of the complexes in 
cancer cells, while being inactive in normal cells, thus 
providing desirable selectivity and cancer cell targeting 
property, shows the significance of this study. 
 
Materials and Methods 
All the reagents and chemicals were purchased 
from commercial sources (SD Fine Chemicals, India; 
Aldrich, USA) and solvents were purified by standard 
procedures.
27
 Calf thymus (ct) DNA, ethidium 
bromide (EB), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), 2,7-dichloro-
fluoresceindiacetate (DCFDA), propidium iodide (PI), 
Dulbecco’s modified eagle medium (DMEM), 
Dulbecco’s phosphate buffered saline (DPBS) and 
fetal bovine serum (FBS) were procured from Sigma, 
USA. Tris-(hydroxymethyl)aminomethane-HCl (Tris-
HCl) buffer solution was prepared using deionized 
and sonicated triply distilled water. The N,N,N-donor 
polypyridyl bases 2-(2-pyridyl)-1,10-phenanthroline 
(pyphen) and 3-(pyridin-2-yl)dipyrido[3,2-a:2',3'-c]-
phenazine (pydppz) were prepared by following 
literature procedures.
28,29 
The complexes were 
characterized by: (i) elemental analyses (Thermo 
Finnigan Flash EA 1112 CHNS analyser), (ii) infrared 
spectra (Bruker ALPHA FT-IR spectrometer),  
(iii) electronic spectra (Perkin-Elmer Lambda  
650 spectrophotometer), (iv) molar conductivity 
(Control Dynamics (India) conductivity meter),  
(v) electrospray ionization mass spectra  
(ESI-MS) (Bruker Daltonics make Esquire 300 Plus 
ESI model), and (vi) 
1
H NMR spectra of the ligands  
at room temperature (Bruker 400 MHz NMR 
spectrometer). Flow cytometry (FACS) measurements 
were made using BD FACS Verse cytometer. 
 
 
Synthesis of the complexes 
Complexes 1 and 2 were prepared by following a 
general synthetic procedure in which vanadium(III) 
chloride (1.0 mmol) was dissolved in 10 mL methanol 
and was stirred in air for 30 min during which the 
solution turned green. The solution was deaerated and 
then saturated with nitrogen. A 1.0 mmol methanolic 
solution of the ligand was added to this solution. The 
reaction mixture was stirred at room temperature and 
the complexes were precipitated after 1 h. The solid 
was isolated and washed with cold ethanol, 
tetrahydrofuran, cold acetonitrile, and was finally 




dried in vacuum over P4O10 (Yield: ~65% for 1 and 
~80% for 2). The characterization data for the 
complexes are available in our preliminary report 




DNA binding experiments  
The fluorescence spectra of the ethidium bromide 
(EB, 50 µM) intercalated ct-DNA (200 µM) were 
recorded (λex = 546 nm, λem = 595 nm) in presence of 
the complexes 1 and 2 (10% DMF-DPBS, pH = 7.2) 
in the dark and under photo-irradiated conditions 
(400-700 nm, 10 J cm
-2
, Luzchem photoreactor). 
Thiourea, which supresses the formation of 
crosslinks by reacting with DNA adducts, was used 
to assess the extent of DNA adduct formation.
30
 The 
solutions were treated with excess of thiourea (10 mM) 
and the emission spectra were recorded. DNA 
melting experiments were carried out by monitoring 
the absorbance of ct-DNA (200 µM) at 260 nm at 
various temperatures, both in the absence and 
presence of the complexes (25 µM). Measurements 
were carried out using a Perkin-Elmer Lambda 650 
spectrometer with a temperature controller at an 
increase rate of 0.5 °C per min of the solution. 
Ethidium bromide (EB) was used as a control. 
Viscometric titrations were performed with a Schott 
Gerate AVS 310 automated viscometer that was 
maintained at 37 °C in a constant temperature bath. 
The concentration of ct-DNA was 150 µM in NP 
(nucleotide pair) and the flow times were measured 
using an automated timer. Each sample was 
measured three times and an average flow time was 
calculated. Data were presented as (η/η0)
1/3
 versus 
[complex]/ [DNA], where η is the viscosity of  
DNA in the presence of complex and η0 is that of 
DNA alone. Viscosity values were calculated  
from the observed flow time of DNA-containing 
solutions (t) corrected for that of the buffer alone 
(t0); η = (t−t0)/t0. Due corrections were made for the 
viscosity of DMF solvent present in the solution. 
 
DNA cleavage experiments 
The photo-induced plasmid DNA cleavage activity 
of the complexes 1 and 2 was studied using 
supercoiled (SC) pUC19 DNA (33.3 µM, 0.2 µg) in a 
medium of Tris-HCl/NaCl (50 mM, pH 7.2) buffer on 
irradiation with visible light of wavelength 476 nm 
(50 mW) using a CW argon-krypton mixed gas ion 
laser. The nature of ROS generated on photo-
irradiation was investigated by studying the 
mechanistic aspects of the DNA photocleavage in the 
presence of several quenchers and scavengers like 
DABCO (1,4-diazabicyclo[2.2.2]octane), L-histidine, 
NaN3 and TEMP (2,2,6,6-tetramethylpiperidine) as 
singlet oxygen quenchers, KI and DMSO as hydroxyl 
radical scavengers, catalase as a H2O2 scavenger,  
and superoxide dismutase (SOD) as a superoxide 
radical scavenger. 
 
Cytotoxicity from MTT assay 
Cytotoxicity of the complexes using 3T3 
embryonic fibroblast normal cells was determined by 
MTT assay in light and dark by an earlier reported 
procedure.
31
 Approximately 1.0 x 10
4
 3T3 embryonic 
fibroblast normal cells were plated in each well of a 
96-well cell culture plate in DMEM cell culture 
medium supplemented with 10% fetal bovine serum 
(10% DMEM) and cultured for 12 h at 37 °C in 5% 
CO2. Various concentrations of the complexes 
dissolved in 1% DMSO were added to the cells and 
incubated for 4 h in dark. The media was 
subsequently replaced with DPBS and the cells were 
irradiated with a broad band visible light for 1 h 
(400−700 nm, 10 J cm
−2
), using a Luzchem 
photoreactor (model LZC-1, Ontario, Canada). After 
photo-irradiation, DPBS was removed and replaced 
with 10% DMEM, and incubation was continued for a 
further period of 20 h in dark. After the incubation,  
5 mg mL
-1
 of MTT (20 µL) was added to each well 
and incubated for another 3 h. The culture medium 
was discarded and 200 µL of DMSO was added to 
dissolve the formazan crystals. The absorbance was 
measured at 540 nm using Spectra Max M5 plate 
reader (Molecular Devices). Cytotoxicity of the 
complexes was determined as the percentage ratio of 
the absorbance of the treated cells to the untreated 
controls. The IC50 values were obtained by nonlinear 
regression analysis (GraphPad Prism 5). 
 
ROS from DCFDA assay 
The formation of reactive oxygen species (ROS) 
was studied using 2’,7’-dichlorodihydrofluorescein 
diacetate (DCFDA) assay. Cell permeable DCFDA 
dye on oxidation by cellular ROS generates 
fluorescent DCF having an emission maximum at  
528 nm.
32
 The percentage of cells generating ROS 
was determined by flow cytometry analysis. HeLa 
cells incubated with 1 µM of complex 2 for 4 h were 
photo-irradiated (400-700 nm) for 1 h in DPBS 
buffer. The cells were then isolated by trypsinization 





prepared. The cells were treated with 10 µM DCFDA 




solution in the dark for 15 min at room temperature. 
The distribution of DCFDA stained HeLa cells was 
determined by flow cytometry. 
 
Cell cycle analysis 
To investigate the effect of the complexes on the 
cell cycle, 2×10
5
 HeLa cells were plated in each well 
of a 24-wells tissue culture plate in 10% DMEM. 
After 12 h of incubation at 37 °C in a CO2 incubator, 
the cells were treated with DMSO solutions of the 
complexes 1 (2 µM) and 2 (1 µM) for 4 h in dark. The 
medium was subsequently replaced with DPBS and 
the cells were photo-irradiated for 1 h. After light 
irradiation, DPBS was removed and replaced with 
10% DMEM, and incubation was continued in the 
dark for a further period of either 12 h or 16 h. The 
cells were then trypsinized and collected into 1.5 mL 
centrifuge tubes, washed once with DPBS and fixed 
by adding 1.0 mL of chilled 70% ethanol. The cell 
suspensions were incubated at −20 °C for 24 h. The 
fixed cells were then washed twice with 1.0 mL of 
DPBS by centrifuging at 5000 rpm at 4 °C for 5 min. 
The supernatants were gently discarded, and the cell 
pellets were suspended in 200 µL of DPBS containing 
50 µg mL
-1
 DNase-free RNase and incubated at 42 °C 
for 1 h. After digestion of cellular RNA, the cells 
were stained with 20 µg mL
-1
 propidium iodide (PI) 
solution for 15 min at 4 °C. Flow cytometric analysis 
was performed using a FACS Verse Becton 
Dickinson (BD) cell analyser. Data analysis was 
performed by using Cyflogic software. 
 
Results and Discussion 
 
Synthesis and general aspects 
The complexes were synthesized and characterized 
using various analytical and spectroscopic methods 
that are reported in our preliminary communication.
23
 
The complexes, viz. [VO(pyphen)Cl2] (1) and 
[VO(pydppz)Cl2] (2), have six coordinate structures 
in which the polypyridyl bases display N,N, 
N-tridentate chelating mode of coordination. The 
disposition of the two chlorides could be cis or 
trans to each other as the energy difference 
between the two structures (0.5-0.7 kcal mol
-1
) is 
insignificant indicating equal possibility of both the 
structures.
23
 The structure having two chloride 
ligands in trans disposition is of marginally lower 
energy than that of the cis analogue. The complexes 
showed good solubility in most polar solvents and are 
non-electrolytes. They displayed 1:1 electrolytic 
behaviour in 20% aqueous DMF, and 1:2 electrolytic 
character in 20% aqueous DMF upon photo-
irradiation with visible light (400–700 nm). The rapid 
loss of one chloride on dissolution of the complex 
in aqueous medium is likely to form the same 
species from both cis and trans dichloro species. 
The trans orientation of the chlorides is supported 
by the IR data showing different V=O stretching 
frequencies for the pyphen and pydppz complexes. 
A cis disposition of two chloride ligands is likely to 
result in the V=O bond frequency remaining 





DNA binding studies 
With the knowledge that planar polypyridyl bases 
can bind to DNA grooves or intercalate within base 
pairs and that loss of chloride ligand(s) can promote 
ICL formation, DNA binding data can give important 
insights into their anticancer properties. The 
complexes could show dual DNA binding properties. 
Ethidium bromide (EB) intercalates to calf thymus 
DNA and being trapped in a hydrophobic 
environment created by the base pairs, displays 
fluorescence which is otherwise not present in the 
aqueous solutions. Addition of the complexes showed 
a gradual decrease of the fluorescence intensity of 
intercalated EB due to its displacement (Fig. 1).
33,34
 








To get information about any ICL formation 
instead of intercalative DNA binding, the stability  
of the DNA double helix upon binding to 1 and 2 
(Fig. 2a) was investigated by thermal denaturation 
experiments. A small positive shift of the DNA 
melting temperature (∆Tm ~1 °C) was observed upon 
addition of complex 1 to ct-DNA. This low ∆Tm value 
suggests the primarily crosslinking nature of the 
complex to ct-DNA in preference to an intercalative 
mode of binding that normally results in a large 
positive ∆Tm value (10 °C for intercalative EB).
35 
The 
∆Tm value for the pydppz complex 2 is marginally 
higher (∆Tm ~3 °C) than that of the pyphen complex 1 
possibly due to the presence of an extended aromatic 
ring that may facilitate partial intercalative DNA 
binding. Viscosity measurements were made to 
examine the effect of the complexes on the specific 
relative viscosity of DNA (Fig. 2b). The relative 
specific viscosity η/η0 (where η and η0 are the 
specific viscosities of DNA in the presence and 
absence of the complexes, respectively) of DNA gives 
a measure of the increase of the contour length 




associated with the separation of DNA base pairs 
caused by intercalation and a classical DNA 
intercalator like ethidium bromide would show a 
significant increase in the viscosity of the DNA 
solutions. In contrast, a partially DNA intercalating 
complex would result in a less  pronounced  effect  on 
the viscosity.
36 
The groove binder Hoechst 33258 
was used as a reference compound that showed an 
insignificant increase in viscosity. The viscosity 
profile of the pydppz complex 2 is also similar to 
 
 
Fig. 1 – Ethidum bromide (EB) displacement assay showing DNA crosslink formation upon photo-exposure of (a) complex 1, and 
(b) complex 2, treated with ethidum bromide (EB, 50 µM) intercalated ct-DNA (200 µM). Emission recorded in dark and light as shown 
in the figure [λexc = 546 nm, λem = 595 nm, photoreactor of 400-700 nm].  
 
 
Fig. 2 – (a) Thermal denaturation plots of 200 µM ct-DNA alone and on addition of the complexes 1 and 2 on exposure to light of 
400-700 nm (10 J cm-2). (b) Effect of addition of complex 1, cisplatin (CP) , DNA intercalator ethidium bromide (EB) and groove binder 
Hoechst dye on the relative viscosity of ct-DNA (200 µM) in DPBS [pH = 7.2]. 




that of EB, indicating a partial DNA intercalative 
mode of binding of the pydppz complex in addition 
to its DNA crosslinking property. Interestingly,  
the viscosity profile of complex 1 compared  





DNA cleavage and mechanistic aspects 
The primary target of binding of these complexes 
is DNA, hence their DNA cleavage property is of 
importance. The complexes showed plasmid 
supercoiled (SC) pUC19 DNA cleavage activity in 
blue light of 476 nm, forming nicked circular (NC) 
DNA (Fig. 3). The possibility of involvement of any 
reactive oxygen species (ROS) was probed by 
mechanistic studies. Addition of singlet oxygen 
quenchers like DABCO, TEMP, sodium azide, and  
L-histidine showed no inhibitory effect on the DNA 
cleavage activity of complex 2. The %NC remained 
above 85% even in the presence of these 
1
O2 
quenchers. Interestingly, hydroxyl radical scavengers 
like DMSO and KI displayed a significant reduction 
in the DNA cleavage activity at this wavelength. 
Catalase as hydrogen peroxide scavenger and SOD 
as superoxide scavenger showed significant 
inhibition of the DNA cleavage activity, with the 
formation of just ~30% NC DNA. The results 
suggest the involvement of hydroxyl radicals (HO
•
) 
as the ROS in the DNA photocleavage reactions  
in visible light. In the absence of any enhancement 
of the DNA cleavage activity in the presence of  






The groove-binding preference of the complexes 
was studied by using DNA minor groove-binder 
distamycin-A, which alone showed ∼20% cleavage 
of the SC DNA at 476 nm for an exposure time of  
2 h. The DNA cleavage activity of 2 remained 
unaffected in the presence of distamycin-A, 
indicating major groove interaction of the pydppz 
complex. Complex 1 showed ~19% of the NC  
form under similar conditions. The DNA cleavage 
activity was also studied under anaerobic medium 
using argon. Photocleavage of ~12% of SC DNA 
was observed under such conditions (Fig. 3). The 
plasmid DNA photocleavage data suggest the 
formation of hydroxyl radicals as the ROS, binding 
of the polypyridyl groups at the major groove of 
DNA, requirement of molecular oxygen for their 
activity, and the dual possibility of groove binding 
and ICL formation. 
 
Photocytotoxicity and cellular properties 
Photo-induced cytotoxicity of complexes 1 and 2 
has been reported earlier in HeLa and MCF-7 cancer 
cells.
23
 The respective IC50 values for the complexes 1 
and 2 were 16.9 µM and 0.87 µM in HeLa and 19.5 µM 
and 1.4 µM in MCF-7 cells in light (400-700 nm, 1 h 
photoexposure, 10 J cm
-2
, Luzchem photoreactor) and 
>40 µM in dark for both the cells. An important 
aspect of anticancer drugs is their selectivity between 
normal and cancer cells. Reduced toxicity for normal 
cells enhances the efficacy of the drug. We have 
studied the photocytotoxicity of the complexes in 3T3 
embryonic fibroblast normal cells by MTT assay.  
The complexes upon prior incubation for 4 h in dark 
and subsequent photo-exposure to visible light of  
400-700 nm (Luzchem photoreactor) for 1 h did not 
show any significant dose-dependent decrease in cell 
viability. The IC50 value was 26.0 (±1.7) µM for the 
pydppz complex 2 and 42.0 (±1.4) µM for complex 1 
(Fig. 4(a), Table 1). The cells unexposed to light gave 
an IC50 value of >50 µM for both the complexes.  
The  pyphen  complex  being   photo-inactive  showed  
 
 
Fig. 3 – Gel diagram showing the mechanistic aspects of DNA photo-cleavage activity of complex 2 (50 µM) on SC pUC19 DNA 
(0.2 µg, 33.3 µM) in the presence of various singlet oxygen quenchers and radical scavengers under irradiation with blue laser light of 
476 nm (50 mW, 120 min exposure, lanes 3-14). [Lane 1, DNA alone; lane 2, DNA + 2 (Dark); lane 3, DNA + 2 (Light); lane 4, DNA+2
+ KI (0.5 mM); lane 5, DNA + 2 + catalase (4 µL) ; lane 6, DNA + 2 + DMSO (4 µL) ; lane 7: DNA+ 2 + SOD (superoxide dismutase, 4 
units); lane 8, DNA + 2 + L-histidine (0.5 mM) ; lane 9, DNA+ 2 + DABCO (0.5 mM); lane 10: DNA+ 2 + NaN3 (0.5 mM); lane 11, 
DNA+ 2 + TEMP (0.5 mM) ; lane 12, DNA+ 2 + D2O (16 µL); lane 13, DNA + 2 + Argon; lane 14, DNA + distamycin-A (50 µM) + 2]. 
 





Table 1 — IC50 (µM) values of the complexes 1 and 2 in different cell lines 
Complex IC50 (µM) 
HeLaa  MCF-7b  3T3c 
 Lightd Dark  Lightd Dark  Lightd Dark 
1 16.9±0.6 >50  19.5±0.3 >50  42.0 ±1.4 >50 
2 0.87±0.07 >40  1.4±0.2 >40  26.0 ±1.7 >50 
aHuman cervical cancer cell line. bHuman breast cancer cell line. cNormal embryonic fibroblast cell line.  




Fig. 4 – (a) Photocytotoxicity of the complexes 1 and 2 in 3T3 normal cells on 4 h incubation in dark followed by exposure to light of 
400-700 nm (Luzchem photoreactor of power 10 J cm-2). (b) DCFDA assay for generation of ROS in HeLa cells upon exposure of visible 
light. [1, Fluorescence of cells alone; 2, fluorescence of cells + DCFDA; 3, fluorescence of cells + DCFDA + 2 in dark; 4, fluorescence of 




Fig. 5 – Cell cycle profile (sub-G1, G1, S, and G2/M phases) of the HeLa cells treated with complexes 1 (2 µM) and 2 (1 µM) in dark and 
after irradiation with visible light (400−700 nm, 10 J cm−2). 




significantly lower activity than the photoactive 
pydppz complex. Both the complexes, however, 
displayed similar ICL properties. The observed lower 
activity of the complexes in normal cells compared to 
those in cancer cells may be due to their lower 
cellular uptake in normal cells. The DNA 
photocleavage study showed the formation of 
hydroxyl radicals as the reactive oxygen species 
(ROS), which is further supported by the DCFDA 
assay that detects formation of any cellular ROS. Cell 
permeable DCFDA on oxidation by cellular ROS 
generates the fluorescent product DCF which has an 
emission maximum at 525 nm; its formation can be 
detected by flow cytometry analysis. A substantial 
positive shift in the fluorescence (indicating ROS 
generation) was observed for HeLa cells treated with 
the photoactive pydppz complex 2 upon irradiation 
with visible light of 400-700 nm when compared to 
the reaction in the dark as well as for the untreated 
cells (Fig. 4(b)). 
The DNA content of the HeLa cells treated  
with the complexes 1 and 2 was measured to 
examine the effect of the complexes on the cell cycle 
using a red-emitting fluorescent dye, viz. propidium 
iodide (PI), by flow cytometry (Fig. 5). The 
experiments were performed under both light and 
dark conditions. The complexes upon light activation 
caused irreparable DNA damage which could lead to 
a G2/M arrest in the cells (12 h) and eventually 
resulting in their death (16 h). In the dark, the 
complexes did not induce any apparent change in 
either G2/M or sub-G1 population of the cells, thus 
emphasising the role of light activation in cell cycle 
arrest and cell death.  
 
Conclusions 
Dichlorooxovanadium(IV) complexes of polypyridyl 
bases having one dissociable and one photo-
dissociable chloride ligand were designed as 
vanadium-based DNA crosslinking agents. The 
incorporation of rigid polypyridyl bases in the 
complexes facilitates the damage of nuclear DNA in a 
manner similar to that known for cisplatin as a 
transcription inhibitor and ICL generator. The  
ct-DNA binding and plasmid DNA photocleavage 
studies show that complex 1 with a 
dichlorooxovanadium(IV) moiety and pyphen ligand, 
forms DNA crosslinks only upon light activation, 
whereas complex 2 having a dppz ligand with an 
additional aromatic moiety displayed a partial 
intercalative mode of DNA binding along with  
DNA crosslinks formation. Complex 2 also exhibited 
excellent DNA cleavage activity upon photo-
irradiation via the hydroxyl radical pathway,  
which was established from the pUC19 DNA  
photo-cleavage mechanistic study and DCFDA assay. 
To ascertain the possibility of any damage induced by 
the complexes to the normal healthy cells, MTT assay 
was performed in normal 3T3 embryonic fibroblast 
cells; no significant cytotoxicity was observed upon 
photo-irradiation. The IC50 values were significantly 
higher in normal cells in comparison to the cancerous 
HeLa and MCF-7 cells.
23
 These results are of 
importance considering the selectivity observed  
and the importance of DNA inter-strand crosslink 
formation which is unlikely to get repaired by nuclear 
excision repair (NER) mechanism that operates for 
intra-strand DNA crosslinks.  
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